X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (385) 385
male (330) 330
middle aged (228) 228
aged (209) 209
female (180) 180
adult (179) 179
index medicus (147) 147
urology & nephrology (144) 144
oncology (120) 120
cancer (96) 96
aged, 80 and over (89) 89
japan - epidemiology (71) 71
risk factors (69) 69
urology (68) 68
japan (65) 65
animals (57) 57
performing operations (54) 54
transporting (54) 54
physical or chemical processes or apparatus in general (50) 50
prostate cancer (50) 50
separation (50) 50
treatment outcome (49) 49
prognosis (48) 48
prostatic neoplasms - pathology (47) 47
cohort studies (46) 46
public, environmental & occupational health (42) 42
chemotherapy (41) 41
renal cell carcinoma (39) 39
retrospective studies (39) 39
tumors (38) 38
analysis (37) 37
cell line, tumor (37) 37
care and treatment (32) 32
expression (32) 32
kidney neoplasms - pathology (32) 32
adolescent (31) 31
apoptosis (30) 30
mice (30) 30
neoplasm staging (30) 30
research (29) 29
proportional hazards models (28) 28
prospective studies (28) 28
risk assessment (28) 28
bladder cancer (27) 27
follow-up studies (27) 27
risk (27) 27
urinary bladder neoplasms - pathology (27) 27
combined modality therapy (26) 26
men (26) 26
epidemiology (25) 25
mortality (25) 25
surgery (25) 25
carcinoma (24) 24
kidney neoplasms - drug therapy (23) 23
surveys and questionnaires (23) 23
child (22) 22
therapy (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
carcinoma, renal cell - drug therapy (21) 21
carcinoma, renal cell - pathology (21) 21
health aspects (21) 21
prostate-specific antigen - blood (21) 21
survival rate (21) 21
time factors (21) 21
young adult (21) 21
incidence (20) 20
kidney neoplasms - surgery (20) 20
survival (20) 20
testicular cancer (20) 20
case-control studies (19) 19
disease-free survival (19) 19
metastasis (19) 19
multivariate analysis (19) 19
oncology, experimental (19) 19
prostate (19) 19
rats (19) 19
further section (18) 18
immunohistochemistry (18) 18
nephrectomy (18) 18
prostatic neoplasms - diagnosis (18) 18
smoking (18) 18
apoptosis - drug effects (17) 17
medical colleges (17) 17
prostatic neoplasms - drug therapy (17) 17
prostatic neoplasms - metabolism (17) 17
tumor cells, cultured (17) 17
germ cell tumor (16) 16
kidney neoplasms - therapy (16) 16
laparoscopy (16) 16
life style (16) 16
predictive value of tests (16) 16
age factors (15) 15
antineoplastic agents - therapeutic use (15) 15
biochemistry & molecular biology (15) 15
disease progression (15) 15
gene expression regulation, neoplastic (15) 15
japanese (15) 15
medicine & public health (15) 15
prevalence (15) 15
testicular neoplasms - pathology (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature medicine, ISSN 1546-170X, 2012, Volume 18, Issue 8, pp. 1254 - 1261
IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs) confirmed to be naturally... 
MEDICINE, RESEARCH & EXPERIMENTAL | COLONY-STIMULATING FACTOR | DENDRITIC CELLS | HIGH-FREQUENCIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | MELANOMA PATIENTS | IDENTIFICATION | TUMOR-ANTIGEN | CUTTING EDGE | CELL BIOLOGY | MYELOID SUPPRESSOR-CELLS | REGULATORY T-CELLS | PEPTIDE VACCINE | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Prognosis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Kidney Neoplasms - immunology | Immunotherapy, Active | Male | Lymphocyte Depletion | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Carcinoma, Renal Cell - immunology | Cyclophosphamide - therapeutic use | Kidney Neoplasms - blood | T-Lymphocytes, Regulatory - immunology | Cancer Vaccines - therapeutic use | Vaccines, Subunit - therapeutic use | Female | Carcinoma, Renal Cell - drug therapy | Immunosuppressive Agents - pharmacology | Chemokine CCL17 - blood | Immunosuppressive Agents - administration & dosage | Kidney Neoplasms - therapy | Carcinoma, Renal Cell - blood | HLA-A2 Antigen - immunology | Antigens, Neoplasm - immunology | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | T-Lymphocytes, Regulatory - drug effects | Cyclophosphamide - pharmacology | Biomarkers | Carcinoma, Renal Cell - therapy | CD8-Positive T-Lymphocytes - immunology | Kidney Neoplasms - drug therapy | Apolipoprotein A-I - blood | Cancer vaccines | Cyclophosphamide | Polypeptides | Immune response | Dosage and administration | Research | Health aspects | Kidney diseases | Peptides | Gene expression | Medical prognosis | Cancer | Immune system
Journal Article
Cancer Science, ISSN 1347-9032, 12/2014, Volume 105, Issue 12, pp. 1616 - 1625
RNAi enables potent and specific gene silencing, potentially offering useful means for treatment of cancers. However, safe and efficient drug delivery systems... 
renal cell carcinoma | RNA interference | Drug delivery system | vascularendothelial growth factor | nanogel | Nanogel | Renal cell carcinoma | Vascularendothelial growth factor | RNA | ONCOLOGY | INFLAMMATION | SUPPRESSOR-CELLS | CANCER | Genetic Therapy | Carcinoma, Renal Cell - pathology | Humans | Gene Expression Regulation, Neoplastic | Tumor Microenvironment | Polyethylene Glycols - chemistry | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Organ Specificity | Drug Delivery Systems | Neovascularization, Pathologic - pathology | Animals | Cyclodextrins - administration & dosage | Polyethyleneimine - chemistry | Carcinoma, Renal Cell - therapy | Cell Line, Tumor | Neoplasms, Experimental | Kidney Neoplasms - pathology | Mice | RNA, Small Interfering - administration & dosage | Carcinoma, Renal Cell - blood supply | Kidney Neoplasms - blood supply | Kidney Neoplasms - therapy | Neovascularization, Pathologic - therapy | Viscosity | Drug delivery systems | Hydrogels | Laboratories | Cycloamylose | Drug delivery | Glucose | Suppressor cells | Experiments | Vascularization | Nanoparticles | Angiogenesis | Lymphocytes | Immunotherapy | Polymers | Vascular endothelial growth factor | Spleen | Immunoglobulins | Immune response | Tumor cells | RNA-mediated interference | siRNA | Cholesterol | Gene silencing | Spermine | Clear cell-type renal cell carcinoma | Tumors | Original
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 2, p. e55922
...Author(s): Masakatsu Oishi 1 , 2 , Yosuke Iizumi 1 , Tomoyuki Taniguchi 1 , Wakana Goi 1 , Tsuneharu Miki 2 , Toshiyuki Sakai 1 , * Introduction Prostate... 
PROTEIN | MITOXANTRONE | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY | DOWN-REGULATION | C-FLIP | TUMOR | RESISTANCE | RECEPTOR | TRAIL-INDUCED APOPTOSIS | UP-REGULATION | RNA, Small Interfering - genetics | Apoptosis - drug effects | Humans | Adenine Nucleotide Translocator 2 - metabolism | Genistein - chemistry | Male | Adenine Nucleotide Translocator 2 - antagonists & inhibitors | Cell Line, Tumor - drug effects | Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism | Apigenin - chemistry | Gene Knockdown Techniques | Drug Synergism | Up-Regulation - drug effects | Adenine Nucleotide Translocator 2 - genetics | TNF-Related Apoptosis-Inducing Ligand - pharmacology | Protein Binding | Antineoplastic Agents - pharmacology | Receptors, TNF-Related Apoptosis-Inducing Ligand - genetics | Apigenin - pharmacology | Prostatic Neoplasms - drug therapy | Purines | Care and treatment | Tumor necrosis factor | Cancer cells | Binding proteins | Adenylic acid | Health aspects | Prostate cancer | Protein binding | Isoflavones | Apoptosis | Cancer | Post-transcription | Genistein | Clinical trials | Science | Translocase | Cancer therapies | Urology | Anticancer properties | Proteins | Antitumor agents | Penicillin | Polyphenols | Tumor necrosis factor-TNF | Binding | Medical research | Immunoglobulins | Tumor cells | Adenine | Pharmacology | Breast cancer | Chemical compounds | Disease prevention | Medicine | Gene silencing | Flavonoids | Diet | Ligands | TRAIL protein | Prostate | Tumors | Recombinant
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2016, Volume 11, Issue 2, pp. e0148177 - e0148177
...], Katsunori Tatsugami [sup.17], Hideki Enokida [sup.18], Michiaki Kubo [sup.1], Tsuneharu Miki [sup.4], Taisei Mushiroda [sup.1]* Introduction Molecular targeting drugs... 
TYROSINE KINASE INHIBITORS | LUNG-CANCER | INTERFERON-ALPHA | GEFITINIB | EFFICACY | MULTIDISCIPLINARY SCIENCES | MUTATIONS | ANTITUMOR-ACTIVITY | RENAL-CELL CARCINOMA | SINGLE-NUCLEOTIDE POLYMORPHISMS | ENDOTHELIAL GROWTH-FACTOR | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Kidney Neoplasms - genetics | Pyrroles - pharmacokinetics | Humans | Middle Aged | Asian Continental Ancestry Group - genetics | Carcinoma, Renal Cell - genetics | Male | Kidney Neoplasms - metabolism | Case-Control Studies | Thrombocytopenia - genetics | ATP-Binding Cassette Transporters - genetics | Antineoplastic Agents - adverse effects | Aged, 80 and over | Pyrroles - adverse effects | Adult | Female | Antineoplastic Agents - pharmacokinetics | Carcinoma, Renal Cell - drug therapy | Neoplasm Proteins - genetics | Genetic Association Studies | Japan | Thrombocytopenia - chemically induced | Carcinoma, Renal Cell - metabolism | Indoles - adverse effects | Indoles - pharmacokinetics | Aged | Polymorphism, Single Nucleotide | Kidney Neoplasms - drug therapy | Amino Acid Substitution | Drugs | Genetic variation | Physiological aspects | Adverse and side effects | Development and progression | Genetic aspects | Research | Toxicity | Variability | Metastasis | Multivariate analysis | Kinases | Drug resistance | Cancer therapies | Proteins | ABCG2 gene | Quality | Vascular endothelial growth factor | Protein-tyrosine kinase | Age | University graduates | Tyrosine | Hypertension | Thrombocytopenia | Pharmacology | Breast cancer | Regression analysis | Metabolism | Patients | Medicine | Side effects | Chemotherapy | University faculty | Pharmacokinetics | Clear cell-type renal cell carcinoma | Kidney transplantation | Index Medicus
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2015, Volume 37, Issue 6, pp. 1259 - 1269
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 8/2015, Volume 20, Issue 4, pp. 790 - 795
Journal Article
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 8/2016, Volume 21, Issue 4, pp. 791 - 795
Journal Article
Journal Article
亚洲男性学杂志:英文版, ISSN 1008-682X, 2015, Volume 17, Issue 6, pp. 863 - 863
The International Prostate Forum (IPF) originally started with three urology departments in Japan, Turkey, and the United States. The forum emphasized... 
论坛 | 前列腺癌 | 国际 | 土耳其 | 历史 | 泌尿科 | 前列腺疾病 | IPF | ANDROLOGY | UROLOGY & NEPHROLOGY | Congresses as Topic | Societies, Medical | Turkey | Prostatic Diseases | United States | Humans | Japan | Male | Urology | Services | Medical societies
Journal Article